Towards Healthcare
Life Science Products Market Booms USD 8.65 Bn by 2034

Life Science Products Market Surges in 2025 North America Dominates, Asia-Pacific Rising Fast

Projections indicate that, the global life science products market will increase from USD 3.15 billion in 2024 to USD 8.65 billion by 2034, experiencing a CAGR of 10.56% over the next 10 years.The life science products market is expanding due to growing chronic diseases as well as increasing prenatal diagnostics. North America led the market due to the presence of major research universities.

  • Insight Code: 5888
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The life science products market is projected to reach USD 8.65 billion by 2034, growing at a CAGR of 10.56% from 2024 to 2034.

North America is currently leading the life science products market due to the presence of major research universities.

The life science products market includes 5 segments such as by product type, by technology, by application, by end user, and by region.

Key trends include growth in next-generation oncology research and innovation in newborn and pediatric health screening services.

Increasing chronic diseases are the factor that drives the market.

American Cancer Society, Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.